" class="no-js "lang="en-US"> NuvoAir - Medtech Alert
Wednesday, March 22, 2023

Breaking News

Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Dupixent® (dupilumab) Approved by European Commission as First and Only Targeted Medicine for Children as Young as Six Months Old with Severe Atopic Dermatitis Gamida Cell Announces Changes to Board of Directors Newron Reports Topline Results From All Patients in Study Evaluating Evenamide as Add-on Therapy for Treatment-Resistant Schizophrenia Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer TFS HealthScience Expands Operations into Israel, With Focus on Continuous, Rapid International Expansion
NuvoAir | Pharmtech Focus

NuvoAir

About NuvoAir

NuvoAir

NuvoAir offers a care platform designed to support people with respiratory conditions achieve better outcomes, providers make the right clinical decisions and health plans achieve higher ROI.

Related Story

Clinical Trials

 Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials | Pharmtech Focus

Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials

September 8 2022

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a […]

Diseases

 NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment | Pharmtech Focus|Peter Bradding

NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment

May 26 2022

NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as […]

Fundraising

 NuvoAir Series A Funding Reaches $25M to Expand Patient-Centric Care and Clinical Trials Platform | Pharmtech Focus

NuvoAir Series A Funding Reaches $25M to Expand Patient-Centric Care and Clinical Trials Platform

January 20 2022

NuvoAir, a leading digital healthcare company working in chronic disease management, raised $11M in a […]

Diseases

 NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma | Pharmtech Focus

NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma

August 27 2021

Three new studies show how home monitoring technology – developed by leading digital health company NuvoAir – […]

Diseases

 NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions | Pharmtech Focus

NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions

June 23 2021

NuvoAir – the digital health company on a mission to improve the lives of millions […]